🇺🇸 FDA
Patent

US 8389228

Process for the measurement of the potency of glatiramer acetate

granted A61KA61K31/198A61K38/02

Quick answer

US patent 8389228 (Process for the measurement of the potency of glatiramer acetate) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/198, A61K38/02, A61P, A61P25/00